As of 2025-07-02, the Relative Valuation of Novocure Ltd (NVCR) is (72.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.88 USD, the upside of Novocure Ltd based on Relative Valuation is -503.0%.
The range of the Relative Valuation is (62.32) - (80.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 41.9x - 54.9x | 48.2x |
| Forward P/E multiples | 42.3x - 57.3x | 49.6x |
| Fair Price | (62.32) - (80.91) | (72.05) |
| Upside | -448.6% - -552.5% | -503.0% |
| Date | P/E |
| 2025-06-27 | -12.22 |
| 2025-06-26 | -11.61 |
| 2025-06-25 | -11.76 |
| 2025-06-24 | -11.54 |
| 2025-06-23 | -11.28 |
| 2025-06-20 | -11.33 |
| 2025-06-18 | -11.41 |
| 2025-06-17 | -11.84 |
| 2025-06-16 | -12.16 |
| 2025-06-13 | -11.92 |
| 2025-06-12 | -12.36 |
| 2025-06-11 | -11.79 |
| 2025-06-10 | -12.48 |
| 2025-06-09 | -11.48 |
| 2025-06-06 | -11.54 |
| 2025-06-05 | -11.17 |
| 2025-06-04 | -11.35 |
| 2025-06-03 | -11.57 |
| 2025-06-02 | -11.57 |
| 2025-05-30 | -12.98 |
| 2025-05-29 | -13.17 |
| 2025-05-28 | -13.15 |
| 2025-05-27 | -13.02 |
| 2025-05-23 | -12.59 |
| 2025-05-22 | -12.30 |
| 2025-05-21 | -12.05 |
| 2025-05-20 | -12.36 |
| 2025-05-19 | -12.20 |
| 2025-05-16 | -12.15 |
| 2025-05-15 | -11.94 |
| 2025-05-14 | -11.61 |
| 2025-05-13 | -12.32 |
| 2025-05-12 | -12.61 |
| 2025-05-09 | -11.80 |
| 2025-05-08 | -11.84 |
| 2025-05-07 | -11.31 |
| 2025-05-06 | -11.09 |
| 2025-05-05 | -12.06 |
| 2025-05-02 | -12.32 |
| 2025-05-01 | -12.19 |
| 2025-04-30 | -12.32 |
| 2025-04-29 | -12.42 |
| 2025-04-28 | -12.43 |
| 2025-04-25 | -12.56 |
| 2025-04-24 | -12.60 |
| 2025-04-23 | -12.07 |
| 2025-04-22 | -11.21 |
| 2025-04-21 | -10.58 |
| 2025-04-17 | -10.58 |
| 2025-04-16 | -10.75 |